Author

K. Bag

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

A. Ghosh· 2 shared D. Chatterji· 2 shared N. Jayaraman· 2 shared A. Pal· 1 shared B. Sarkar· 1 shared M. Singla· 1 shared N. P. Bokolia· 1 shared P. K. Maiti· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

A. Ghosh

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A novel vitamin C analog acts as a potent bio-enhancer to augment the activities of anti-tuberculosis drugs against Mycobacterium tuberculosis

N. P. Bokolia, K. Bag, B. Sarkar, R. Jhawar, D. Chatterji, N. Jayaraman, A. Ghosh

The paper identifies a vitamin C analog, C11, that enhances anti-tuberculosis drug efficacy against M. tuberculosis by reducing mutant generation and increasing ROS production.

bioRxiv · Nov 26, 2023 · PreprintMicrobiology

C-4-Modified Isotetrones Prevent Biofilm Growth and Persister Cell Resuscitation in Mycobacterium smegmatis

K. Bag, A. Pal, S. Basu, M. Singla, D. Chatterji, P. K. Maiti, A. Ghosh, N. Jayaraman

This study identifies isotetrone derivatives that inhibit biofilm growth and persister cell formation in M. smegmatis and enhance ciprofloxacin's effectiveness against antibiotic-tolerant cells.

bioRxiv · Oct 23, 2022 · PreprintMicrobiology